Is it possible to determine cytokine concentration in samples with low protein concentrations, such as cerebral spinal fluid (CSF)?
To assay cytokines in samples with low protein concentrations with our EASIA (direct ELISA) kits, one thing to consider is the effect of matrix. Matrix is the liquid environment which surrounds the cytokine. The composition of the matrix can influence the results of the ELISA. The measurement of cytokines with low protein concentrations such as CSF, tissue culture supernatant, broncheolar alveolar lavage fluid, and urine, may produce results which are not truly comparable with a standard curve generated with serum as the matrix. These matrices with low protein concentration should be modified so that they more closely resemble the matrix used to generate the standard curve. We have found that addition of just a single protein component to samples with low protein matrices, such as adding bovine serum albumin, is not sufficient to cause the matrix to resemble that of the standard curve. We suggest several methods to adjust the matrix of samples so that it more closely resembles that of the standard curve. The first method is to dilute the sample 1:4 (one part sample plus three parts diluent) with the diluent provided in the kit (usually Standard Zero). Alternatively, a pool of serum from healthy volunteers may be used in place of the diluent. If pooled serum is used, it is important that the concentration of the cytokine to be measured first be quantitated in this serum and the appropriate correction should be made. An example is given below:
If the pooled serum is found to have 10 pg/mL of the cytokine of interest and cytokine level in the sample diluted 1 part sample in 3 parts pooled serum is measured to be 50 pg/mL, the calculated concentration in the sample is 50 - (10 x 3/4) = 42.5 pg/mL, then correcting for the 1:4 dilution, 42.5 pg/mL x 4 = 170 pg/mL.
A second method for increasing the matrix protein in samples is designated the Point-0-Cytokine (or Point-0-Receptor, depending on the kit) method. This method should be considered for use with samples that have low cytokine concentrations in a matrix with a low protein concentration. The presence of the cytokine at low concentrations does not permit the researcher to dilute the sample 1:4 because the cytokine concentration in the diluted sample would be below the level of detectability by the assay. The use of the Point-0-Cytokine vials allows the researcher to increase the concentration of the protein without diluting the samples. Each vial of Point-0-Cytokine contains lyophilized serum protein. To use the Point-0-Cytokine vials, the researcher simply adds 500 microliters of the low protein sample to the contents of the vials, and allows the serum proteins to rehydrate. Many of the EASIA kits require Point-0-Cytokine vials for low protein, low cytokine containing samples. Other kits require Point-0-Receptor vials which are used in the same manner as the Point-0-Cytokine. CSF requires addition of PT0 cytokine or PT0 receptor, or the normal procedure can be followed, depending on the kit.
Find additional tips, troubleshooting help, and resources within our Antibodies and Immunoassays Support Center.
If the pooled serum is found to have 10 pg/mL of the cytokine of interest and cytokine level in the sample diluted 1 part sample in 3 parts pooled serum is measured to be 50 pg/mL, the calculated concentration in the sample is 50 - (10 x 3/4) = 42.5 pg/mL, then correcting for the 1:4 dilution, 42.5 pg/mL x 4 = 170 pg/mL.
A second method for increasing the matrix protein in samples is designated the Point-0-Cytokine (or Point-0-Receptor, depending on the kit) method. This method should be considered for use with samples that have low cytokine concentrations in a matrix with a low protein concentration. The presence of the cytokine at low concentrations does not permit the researcher to dilute the sample 1:4 because the cytokine concentration in the diluted sample would be below the level of detectability by the assay. The use of the Point-0-Cytokine vials allows the researcher to increase the concentration of the protein without diluting the samples. Each vial of Point-0-Cytokine contains lyophilized serum protein. To use the Point-0-Cytokine vials, the researcher simply adds 500 microliters of the low protein sample to the contents of the vials, and allows the serum proteins to rehydrate. Many of the EASIA kits require Point-0-Cytokine vials for low protein, low cytokine containing samples. Other kits require Point-0-Receptor vials which are used in the same manner as the Point-0-Cytokine. CSF requires addition of PT0 cytokine or PT0 receptor, or the normal procedure can be followed, depending on the kit.
Find additional tips, troubleshooting help, and resources within our Antibodies and Immunoassays Support Center.